ICPY yields 0.27% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, ICPY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ICPY + PFE for your $10,000?
ICPY actively invests in undervalued equity securities globally, targeting firms with insider purchases or opportunistic share buybacks trading below estimated intrinsic value. Insiders include corporate officers and controlling shareholders, identified through public filings. In identifying securities, the adviser uses a quantitative, decision-rule-based process and applies additional screens to evaluate liquidity, free will insider purchases, and intrinsic value of various companies. A systematic buy-sell discipline is also employed, utilizing a quantitative multifactor comparison system informed by proprietary models and qualitative value analysis, to update and refresh the portfolio. This comparison system aids in investment decisions, prioritizing higher-scoring stocks and selling lower-scoring ones. Diversification is maintained across industries, geographies, and market caps, with position sizes generally capped at 2%. The fund seeks long-term capital growth.
Full ICPY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.